Pharmaceutical products | Tenderlake

Pharmaceutical products

Contract Value:
-
Notice Type:
Contract Notice
Published Date:
27 July 2021
Closing Date:
25 August 2021
Location(s):
FRH01 Côtes-d’Armor (FR FRANCE)
Description:
Cancer drugs — cabazitaxel 2021-2024 from 15 September to 31.5.2022, renewable twice until 31.5.2024

Cancer drugs — cabazitaxel 2021-2024 from 15 September to 31.5.2022, renewable twice until 31.5.2024.

Cabazitaxel

Supply of the drug Cabazitaxel.

Download full details as .pdf
The Buyer:
Centre hospitalier de Saint-Brieuc
CPV Code(s):
33600000 - Pharmaceutical products